OTC · Medical - Diagnostics & Research

Cyclo3pss Corporation (CYPS) Stock

$0.00 OTC: CYPS Healthcare

Cyclo3pss Corporation operated primarily in the ozone technology sector. Its business encompassed the licensing, manufacturing, sales, and installation of ozone-based products for food processing, as well as providing ozone washing, sorting, and counting systems for commercial and institutional laundries.

Valuation

MetricValue
Price$0.00
Market Cap$4054
P/E Ratio
P/B Ratio
P/S Ratio0.01
EPS (TTM)$-0.02
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE
ROA-235.75%
ROCE
Gross Margin36.57%
Operating Margin-85.36%
Net Margin-232.29%
Debt/Equity
Current Ratio0.14

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA
FCF Yield
Quick Ratio
Interest Coverage
Return 1Y400.00%
Return 3Y400.00%
Return 5Y

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CVHIFVentura Cannabis & Wellness Corporation $0.00 0.00 $3704 0.00%
EMGEEmergent Health Corp $0.00 -0.02 $4193 0.00%
KLDOKaleido Biosciences, Inc. $0.00 0.00 $426 0.00%
NMRDNemaura Medical Inc. $0.00 0.00 $4035 0.00%
NMXSNet Medical Xpress Solutions, Inc. $0.00 -0.01 $26367 0.00%

About Cyclo3pss Corporation

Cyclo3pss Corporation operated primarily in the ozone technology sector. Its business encompassed the licensing, manufacturing, sales, and installation of ozone-based products for food processing, as well as providing ozone washing, sorting, and counting systems for commercial and institutional laundries. Additionally, the firm was involved in the research and development of sterilization and disinfection technologies for various consumer goods. Established in Salt Lake City, Utah, the company traced its origins back to 1927. However, in July 2002, Cyclo3pss's Board of Directors made the decision to immediately cease all company operations. This drastic step was taken due to an inability to attract willing investors and secure the essential financing required for continued business.

Cyclo3pss Corporation (CYPS) stock trades at $0.00 with a market capitalization of $4054. The stock is valued at price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Cyclo3pss Corporation generates an operating margin of -85.36%, a net profit margin of -232.29%.

Official website: www.cyclo3pss.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides